Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
CAPS2 antisense RNA 1 (CAPS2-AS1) is a long non-coding RNA transcribed from the antisense strand of the genomic locus neighboring the CAPS2 gene[3]. Antisense RNAs, particularly lncRNAs like CAPS2-AS1, function mainly in regulation of gene expression by interacting with sense transcripts or modulating chromatin state at their loci of origin or distant genomic regions[1]. These RNAs do not encode functional proteins, and their regulatory effects may be mediated via several mechanisms including transcriptional interference, RNA-DNA interactions, and recruitment of chromatin modifiers. While many antisense lncRNAs play roles in cancer and other diseases, there is no disease-specific or drug interaction data for CAPS2-AS1 currently available[3][1]. CAPS2-AS1 should not be confused with the CAPS2 (Calcium-dependent activator protein for secretion 2) protein, which is involved in neurosecretion[4]; CAPS2-AS1 itself does not encode a protein and is not a receptor or enzyme. Antisense lncRNAs as a class are of growing interest in epigenetic gene regulation and as potential (but largely exploratory) therapeutic targets; however, CAPS2-AS1 currently has no established therapeutic or diagnostic use[3][1].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on CAPS2 antisense RNA 1 (CAPS2-AS1).